VIVIMEDLAB

HealthcareDrug Manufacturers - Specialty & GenericMicro Cap
Vivimed Labs Limited

Vivimed Labs Limited operates in the Healthcare sector, specifically as a Drug Manufacturer - Specialty & Generic. The company manufactures and sells active pharmaceutical ingredie...

हिन्दी में

Vivimed Labs Limited हेल्थकेयर सेक्टर में एक ड्रग मैन्युफैक्चरर - स्पेशलिटी एंड जेनेरिक के रूप में काम करती है। यह कंपनी भारत में एक्टिव फार्मास्युटिकल इंग्रेडिएंट्स (APIs), फ़िनिश...

₹7.11-1.93%1D
Previous trading day close · Data updates after market close
1W: +13.2%
1M: +15.6%
6M: -2.7%
1Y: +43.6%
43/100
Below AvgResearch Score
Market Cap
₹47 Cr
Micro Cap
P/E Ratio
-1.50
Negative earnings
P/B Ratio
-1.23
Negative book value
ROE
N/A
ROCE
-56.4%
Average
Debt / Equity
N/A
Div. Yield
N/A
EV/EBITDA
-3.12
Negative EBITDA
52W Low: ₹4.75Current: ₹7.1152W High: ₹29.4
At 10% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
66/100
Growth
Revenue, EPS, profit growth
24/100
Valuation
PE, PB, EV/EBITDA vs sector
39/100
Risk
Debt levels, volatility, coverage
31/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
-1.50(Negative earnings)
Forward P/E
N/A
P/B Ratio
-1.23(Negative book value)
P/S Ratio
0.77(Good)
EV/EBITDA
-3.12(Negative EBITDA)
Dividend Yield
N/A
5Y CAGR
N/A
Revenue Growth
-40.5%(Moderate)
Profitability
ROE
N/A
ROCE
-56.4%(Average)
ROA
-12.9%(Average)
Net Margin
-231.3%(Low)
EBITDA Margin
-208.8%
Financial Health
Debt to Equity
N/A
Current Ratio
0.38(Tight)
Quick Ratio
0.10(Tight)
Interest Coverage
-41.29x(Low)
Technical Indicators
Based on previous trading day close
RSI (14)
82(Overbought)
RSI Exp (14)
83(Overbought)
MACD
0.245(Bullish)
MACD Signal
0.061
BB Position
100%(Upper band)
BB Width
39.67%(High volatility)
ADX (14)
61.3(Very Strong)
Williams %R
-13.3(Overbought)
MFI (14)
96(Overbought)
CCI (20)
189(Overbought)
Stoch %K
87(Overbought)
ATR (14)
0.27(Avg True Range)
OBV (M)
-8.0(Negative)
1W OBV Chg
11.5%(Increasing)
Rel Volume
2.06x(High activity)
Volatility
311.7%(High)
Max DD 1Y
-81.7%(High loss)
Alpha (CAPM)
52.19%(Outperforming Nifty)
Return vs Nifty
55.0%(Beating Nifty)
EMA 200
6.3
EMA 50
6.0
SMA 200
7.2
vs SMA 50
20.5%(Above SMA50)
vs SMA 200
-1.3%(Below SMA200)
Volume
1.75L
Avg Vol 3M
0.8L
Shareholding Pattern
Promoter
7.6%
Low stake
FII
1.6%
DII / MF
0.0%
Share VIVIMEDLAB
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.